Download Free Sample Report

Cardiac Safety Assessment Services Market, Global Outlook and Forecast 2023-2029

Cardiac Safety Assessment Services Market, Global Outlook and Forecast 2023-2029

  • Published on : 12 April 2023
  • Pages :104
  • Report Code:SMR-7638266

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Cardiac safety assessment is an important, animal or animal tissue-based experimental procedure that must be considered before entering into clinical trials. In the past few years, some drugs that have been put into clinical use have had to be withdrawn from the market or their approval has been delayed because of their potential cardiotoxicity or causing severe cardiac arrhythmias.
This report aims to provide a comprehensive presentation of the global market for Cardiac Safety Assessment Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Safety Assessment Services. This report contains market size and forecasts of Cardiac Safety Assessment Services in global, including the following market information:
Global Cardiac Safety Assessment Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cardiac Safety Assessment Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Drug-induced cardiotoxicity is one of the main reasons for the termination of research and development of new drugs or their removal from the market. Therefore, cardiac safety assessment is a mandatory experimental procedure for various new drugs to enter clinical trials. At present, "hERG assay (hERG Assay)" (hERG assay is to evaluate the inhibitory effect of drugs on hERc current in stably expressing cell lines) is considered to be the current gold standard for preclinical cardiac safety evaluation, and is also required by FDA for new drug approval. Prepare data.
We surveyed the Cardiac Safety Assessment Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Safety Assessment Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cardiac Safety Assessment Services Market Segment Percentages, by Type, 2022 (%)
ECG/Holter Measurement Service
Blood Pressure Measurement Service
Cardiovascular Imaging
Full QT Test
Global Cardiac Safety Assessment Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cardiac Safety Assessment Services Market Segment Percentages, by Application, 2022 (%)
Commissioned Research Institute
Pharmaceutical Company
College
Other
Global Cardiac Safety Assessment Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cardiac Safety Assessment Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Safety Assessment Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cardiac Safety Assessment Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Laboratory Corporation of America Holdings
Koninklijke Philips
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
SGS S.A
Shanghai Medicilon
Hangzhou Rongchuang Biological Co., Ltd.
Scottish Institute of Electrophysiology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Safety Assessment Services, market overview.
Chapter 2: Global Cardiac Safety Assessment Services market size in revenue.
Chapter 3: Detailed analysis of Cardiac Safety Assessment Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Safety Assessment Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.